Ultragenyx Pharmaceutical, Inc. (RARE)
16.07
-0.20
(-1.23%)
USD |
NASDAQ |
Nov 13, 16:00
16.07
0.00 (0.00%)
After-Hours: 19:59
Ultragenyx Pharmaceutical Debt to Equity Ratio : -3.154 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.154 |
| June 30, 2026 | -4.131 |
| March 31, 2026 | -5.085 |
| December 31, 2025 | -15.65 |
| September 30, 2025 | 94.24 |
| June 30, 2025 | 5.836 |
| March 31, 2025 | 6.168 |
| December 31, 2024 | 3.564 |
| September 30, 2024 | 2.631 |
| June 30, 2024 | 2.143 |
| March 31, 2024 | 6.646 |
| December 31, 2023 | 3.394 |
| September 30, 2023 | 30.04 |
| June 30, 2023 | 7.211 |
| March 31, 2023 | 4.166 |
| December 31, 2022 | 2.573 |
| September 30, 2022 | 1.913 |
| June 30, 2022 | 0.5847 |
| March 31, 2022 | 0.496 |
| December 31, 2021 | 0.4268 |
| September 30, 2021 | 0.42 |
| June 30, 2021 | 0.4014 |
| March 31, 2021 | 0.3663 |
| December 31, 2020 | 0.3326 |
| September 30, 2020 | 0.5636 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.531 |
| March 31, 2020 | 0.5964 |
| December 31, 2019 | 0.539 |
| September 30, 2019 | 0.0529 |
| June 30, 2019 | 0.0488 |
| March 31, 2019 | 0.0319 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ionis Pharmaceuticals, Inc. | 5.520 |
| AbbVie, Inc. | -17.65 |
| Krystal Biotech, Inc. | 0.006 |
| BridgeBio Pharma, Inc. | -2.054 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.187B |
| Total Liabilities (Quarterly) | 1.556B |
| Shareholders Equity (Quarterly) | -376.00M |
| Current Ratio | 1.398 |
| Net Debt Paydown Yield | -3.96% |